Alan Perelson

Government of the United States of America - Los Alamos National Laboratory

Los Alamos, NM 87545

United States

SCHOLARLY PAPERS

1

DOWNLOADS

7

SSRN CITATIONS

0

CROSSREF CITATIONS

0

Scholarly Papers (1)

1.

A Participant-Derived Xenograft Model of HIV Enables Long-Term Evaluation of Autologous Immunotherapies

Number of pages: 63 Posted: 22 May 2020
Weill Cornell Medicine, Government of the United States of America - Los Alamos National Laboratory, George Washington University, School of Medicine and Health Sciences, Infectious Diseases Division, Department of Medicine, Weill Cornell Medical College, Weill Cornell Medicine, Weill Cornell Medicine - Infectious Diseases Division, Weill Cornell Medicine, Infectious Diseases Division, George Washington University - Children's National Medical Center, University of British Columbia (UBC) - British Columbia Centre for Excellence in HIV/AIDS, University of British Columbia (UBC) - British Columbia Centre for Excellence in HIV/AIDS, Repertoire Immune Medicines, Repertoire Immune Medicines, Masssachusetts Institute of Technology and Harvard University - Ragon Institute, University of British Columbia (UBC) - British Columbia Centre for Excellence in HIV/AIDS, Children's National Health System, Government of the United States of America - Los Alamos National Laboratory, Harvard University - Howard Hughes Medical Institute and Weill Cornell Medicine - Infectious Diseases Division
Downloads 7 (655,270)

Abstract:

Loading...

HIV, CD8+ T-cells, immunotherapy, T-cell therapy, immunoengineering, escape mutations, patient derived xenografts